Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Peñagarikano O[au]:

Building Bridges through Science. Lissek T et al. Neuron. (2017)

Neural Circuits for Social Cognition: Implications for Autism. Fernández M et al. Neuroscience. (2018)

Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Peñagarikano O et al. Sci Transl Med. (2015)

Search results

Items: 29

1.

Reduced Prefrontal Synaptic Connectivity and Disturbed Oscillatory Population Dynamics in the CNTNAP2 Model of Autism.

Lazaro MT, Taxidis J, Shuman T, Bachmutsky I, Ikrar T, Santos R, Marcello GM, Mylavarapu A, Chandra S, Foreman A, Goli R, Tran D, Sharma N, Azhdam M, Dong H, Choe KY, Peñagarikano O, Masmanidis SC, Rácz B, Xu X, Geschwind DH, Golshani P.

Cell Rep. 2019 May 28;27(9):2567-2578.e6. doi: 10.1016/j.celrep.2019.05.006.

2.

Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing.

Parras A, Anta H, Santos-Galindo M, Swarup V, Elorza A, Nieto-González JL, Picó S, Hernández IH, Díaz-Hernández JI, Belloc E, Rodolosse A, Parikshak NN, Peñagarikano O, Fernández-Chacón R, Irimia M, Navarro P, Geschwind DH, Méndez R, Lucas JJ.

Nature. 2018 Aug;560(7719):441-446. doi: 10.1038/s41586-018-0423-5. Epub 2018 Aug 15.

3.

Building Bridges through Science.

Lissek T, Adams M, Adelman J, Ahissar E, Akaaboune M, Akil H, al'Absi M, Arain F, Arango-Lasprilla JC, Atasoy D, Avila J, Badawi A, Bading H, Baig AM, Baleriola J, Belmonte C, Bertocchi I, Betz H, Blakemore C, Blanke O, Boehm-Sturm P, Bonhoeffer T, Bonifazi P, Brose N, Campolongo P, Celikel T, Chang CC, Chang TY, Citri A, Cline HT, Cortes JM, Cullen K, Dean K, Delgado-Garcia JM, Desroches M, Disterhoft JF, Dowling JE, Draguhn A, El-Khamisy SF, El Manira A, Enam SA, Encinas JM, Erramuzpe A, Esteban JA, Fariñas I, Fischer E, Fukunaga I, Gabilondo I, Ganten D, Gidon A, Gomez-Esteban JC, Greengard P, Grinevich V, Gruart A, Guillemin R, Hariri AR, Hassan B, Häusser M, Hayashi Y, Hussain NK, Jabbar AA, Jaber M, Jahn R, Janahi EM, Kabbaj M, Kettenmann H, Kindt M, Knafo S, Köhr G, Komai S, Krugers H, Kuhn B, Ghazal NL, Larkum ME, London M, Lutz B, Matute C, Martinez-Millan L, Maroun M, McGaugh J, Moustafa AA, Nasim A, Nave KA, Neher E, Nikolich K, Outeiro T, Palmer LM, Penagarikano O, Perez-Otano I, Pfaff DW, Poucet B, Rahman AU, Ramos-Cabrer P, Rashidy-Pour A, Roberts RJ, Rodrigues S, Sanes JR, Schaefer AT, Segal M, Segev I, Shafqat S, Siddiqui NA, Soreq H, Soriano-García E, Spanagel R, Sprengel R, Stuart G, Südhof TC, Tønnesen J, Treviño M, Uthman BM, Venter JC, Verkhratsky A, Weiss C, Wiesel TN, Yaksi E, Yizhar O, Young LJ, Young P, Zawia NH, Zugaza JL, Hasan MT.

Neuron. 2017 Nov 15;96(4):730-735. doi: 10.1016/j.neuron.2017.09.028.

4.

Neural Circuits for Social Cognition: Implications for Autism.

Fernández M, Mollinedo-Gajate I, Peñagarikano O.

Neuroscience. 2018 Feb 1;370:148-162. doi: 10.1016/j.neuroscience.2017.07.013. Epub 2017 Jul 17. Review.

PMID:
28729065
5.

Your genes are conspiring against you.

Peñagarikano O.

Sci Transl Med. 2017 Feb 8;9(376). pii: eaam6059. doi: 10.1126/scitranslmed.aam6059.

PMID:
28179504
6.

Stress: A deadly weapon.

Peñagarikano O.

Sci Transl Med. 2016 Dec 21;8(370):370ec204. doi: 10.1126/scitranslmed.aal3703. No abstract available.

PMID:
28003543
7.

Oxytocin in animal models of autism spectrum disorder.

Peñagarikano O.

Dev Neurobiol. 2017 Feb;77(2):202-213. doi: 10.1002/dneu.22449. Review.

8.

New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences.

Peñagarikano O.

Exp Neurobiol. 2015 Dec;24(4):301-11. doi: 10.5607/en.2015.24.4.301. Epub 2015 Dec 16. Review.

9.

JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse.

Berg JM, Lee C, Chen L, Galvan L, Cepeda C, Chen JY, Peñagarikano O, Stein JL, Li A, Oguro-Ando A, Miller JA, Vashisht AA, Starks ME, Kite EP, Tam E, Gdalyahu A, Al-Sharif NB, Burkett ZD, White SA, Fears SC, Levine MS, Wohlschlegel JA, Geschwind DH.

Neuron. 2015 Dec 16;88(6):1173-1191. doi: 10.1016/j.neuron.2015.10.031. Epub 2015 Nov 25.

10.

Endocannabinoid signaling mediates oxytocin-driven social reward.

Wei D, Lee D, Cox CD, Karsten CA, Peñagarikano O, Geschwind DH, Gall CM, Piomelli D.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):14084-9. doi: 10.1073/pnas.1509795112. Epub 2015 Oct 26.

11.

Cerebellar associative sensory learning defects in five mouse autism models.

Kloth AD, Badura A, Li A, Cherskov A, Connolly SG, Giovannucci A, Bangash MA, Grasselli G, Peñagarikano O, Piochon C, Tsai PT, Geschwind DH, Hansel C, Sahin M, Takumi T, Worley PF, Wang SS.

Elife. 2015 Jul 9;4:e06085. doi: 10.7554/eLife.06085.

12.

Correction: The Autism Related Protein Contactin-Associated Protein-Like 2 (CNTNAP2) Stabilizes New Spines: An In Vivo Mouse Study.

Gdalyahu A, Lazaro M, Penagarikano O, Golshani P, Trachtenberg JT, Geschwind DH.

PLoS One. 2015 May 29;10(5):e0129638. doi: 10.1371/journal.pone.0129638. eCollection 2015. No abstract available.

13.

VoICE: A semi-automated pipeline for standardizing vocal analysis across models.

Burkett ZD, Day NF, Peñagarikano O, Geschwind DH, White SA.

Sci Rep. 2015 May 28;5:10237. doi: 10.1038/srep10237.

14.

The Autism Related Protein Contactin-Associated Protein-Like 2 (CNTNAP2) Stabilizes New Spines: An In Vivo Mouse Study.

Gdalyahu A, Lazaro M, Penagarikano O, Golshani P, Trachtenberg JT, Geschwind DH.

PLoS One. 2015 May 7;10(5):e0125633. doi: 10.1371/journal.pone.0125633. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0129638. Gescwind, Daniel H [corrected to Geschwind, Daniel H].

15.

3D visualization of the regional differences.

Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, Tam E, Osborne LR, Kouser M, Espinosa-Becerra F, Xuan Z, Powell CM, Raznahan A, Robins DM, Nakai N, Nakatani J, Takumi T, van Eede MC, Kerr TM, Muller C, Blakely RD, Veenstra-VanderWeele J, Henkelman RM, Lerch JP.

Mol Psychiatry. 2015 Feb;20(1):1. doi: 10.1038/mp.2014.168. No abstract available.

16.

The emerging picture of autism spectrum disorder: genetics and pathology.

Chen JA, Peñagarikano O, Belgard TG, Swarup V, Geschwind DH.

Annu Rev Pathol. 2015;10:111-44. doi: 10.1146/annurev-pathol-012414-040405. Review.

PMID:
25621659
17.

Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.

Peñagarikano O, Lázaro MT, Lu XH, Gordon A, Dong H, Lam HA, Peles E, Maidment NT, Murphy NP, Yang XW, Golshani P, Geschwind DH.

Sci Transl Med. 2015 Jan 21;7(271):271ra8. doi: 10.1126/scitranslmed.3010257.

18.

Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity.

Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, Tam E, Osborne LR, Kouser M, Espinosa-Becerra F, Xuan Z, Powell CM, Raznahan A, Robins DM, Nakai N, Nakatani J, Takumi T, van Eede MC, Kerr TM, Muller C, Blakely RD, Veenstra-VanderWeele J, Henkelman RM, Lerch JP.

Mol Psychiatry. 2015 Feb;20(1):118-25. doi: 10.1038/mp.2014.98. Epub 2014 Sep 9.

19.

What does CNTNAP2 reveal about autism spectrum disorder?

Peñagarikano O, Geschwind DH.

Trends Mol Med. 2012 Mar;18(3):156-63. doi: 10.1016/j.molmed.2012.01.003. Epub 2012 Feb 25. Review. Erratum in: Trends Mol Med. 2012 Aug;18(8):502.

20.

Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.

Peñagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, Sonnenblick LI, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg JT, Peles E, Geschwind DH.

Cell. 2011 Sep 30;147(1):235-46. doi: 10.1016/j.cell.2011.08.040.

21.

The pathophysiology of fragile x syndrome.

Penagarikano O, Mulle JG, Warren ST.

Annu Rev Genomics Hum Genet. 2007;8:109-29. Review.

PMID:
17477822
22.

Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation.

Tejada MI, Peñagarikano O, Rodriguez-Revenga L, Martinez-Bouzas C, García B, Bádenas C, Guitart M, Minguez M, García-Alegría E, Sanz-Parra A, Beristain E, Milá M.

Clin Genet. 2006 Aug;70(2):140-4.

PMID:
16879196
23.

Gene symbol: MECP2. Disease: Rett syndrome (atypical).

Penagarikano O, Martinez-Bouzas C, Mínguez M, Sanz-Parra A, García-Alegría E, Beristain E, Tejada MI.

Hum Genet. 2005 Dec;118(3-4):547. No abstract available.

PMID:
16521306
24.

A new insight into fragile X syndrome among Basque population.

Peñagarikano O, Gil A, Télez M, Ortega B, Flores P, Veiga I, Peixoto A, Criado B, Arrieta I.

Am J Med Genet A. 2004 Jul 30;128A(3):250-5.

PMID:
15216545
25.

Dermatoglyphic variation in Spanish Basque populations.

Arrieta I, Martínez B, Criado B, Télez M, Ortega B, Peñagarikano O, Lostao CM.

Hum Biol. 2003 Apr;75(2):265-91.

PMID:
12943163
26.

The FMR1 CGG repeat and linked microsatellite markers in two Basque valleys.

Arrieta I, Peñagarikano O, Télez M, Ortega B, Flores P, Criado B, Veiga I, Peixoto AL, Lostao CM.

Heredity (Edinb). 2003 Mar;90(3):206-11.

27.

Evaluation of the cytogenetic damage induced by the antihypertensive drug nimodipine in human lymphocytes.

Télez M, Martínez B, Criado B, Ortega B, Peñagarikano O, Flores P, Ortiz-Lastra E, Arrieta I.

Mutagenesis. 2001 Jul;16(4):345-51.

PMID:
11420404
28.

In vitro and in vivo evaluation of the antihypertensive drug atenolol in cultured human lymphocytes: effects of long-term therapy.

Télez M, Martínez B, Criado B, Lostao CM, Penagarikano O, Ortega B, Flores P, Ortiz-Lastra E, Alonso RM, Jiménez RM, Arrieta I.

Mutagenesis. 2000 May;15(3):195-202.

PMID:
10792010
29.

A survey of fragile X syndrome in a sample from Spanish Basque country.

Arrieta I, Criado B, Martinez B, Telez M, Nuñez T, Peñagarikano O, Ortega B, Lostao CM.

Ann Genet. 1999;42(4):197-201.

PMID:
10674158

Supplemental Content

Loading ...
Support Center